Cited by

• Preferential binding of mouse mammary tumor virus to B lymphocytes.

  Baribaud F, Shaw AV, Scarpellino L, Diggelmann H, Acha-Orbea H. Baribaud F, et al. J Virol. 1999 Sep;73(9):7899-902. doi: 10.1128/JVI.73.9.7899-7902.1999. J Virol. 1999. PMID: 10438888 Free PMC article.
• Identification of a cellular receptor for mouse mammary tumor virus and mapping of its gene to chromosome 16.

  Hilkens J, van der Zeijst B, Buijs F, Kroezen V, Bleumink N, Hilgers J. Hilkens J, et al. J Virol. 1983 Jan;45(1):140-7. doi: 10.1128/JVI.45.1.140-147.1983. J Virol. 1983. PMID: 6296428 Free PMC article.
• Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.

  Schochetman G, Arthur LO, Long CW, Massey RJ. Schochetman G, et al. J Virol. 1979 Oct;32(1):131-9. doi: 10.1128/JVI.32.1.131-139.1979. J Virol. 1979. PMID: 94356 Free PMC article.
• Mouse mammary tumour virus-like env nucleotide and p14 signal peptide are present in feline mammary carcinomas, but not in neoplastic or dysplastic canine mammary lesions.

  Civita P, Menicagli M, Scopelliti C, Lessi F, Millanta F, Borsacchi S, Parisi F, Freer G, Pistello M, Mazzanti CM, Poli A. Civita P, et al. PLoS One. 2018 Jul 24;13(7):e0200839. doi: 10.1371/journal.pone.0200839. eCollection 2018. PLoS One. 2018. PMID: 30040851 Free PMC article.
• C3H/HeN mammary tumor-bearing mice develop type-specific neutralizing antibodies and group-specific precipitating antibodies for the mouse mammary tumor virus.

  Massey R, Arthur LO, Long CW, Schochetman G. Massey R, et al. J Virol. 1980 Jan;33(1):123-8. doi: 10.1128/JVI.33.1.123-128.1980. J Virol. 1980. PMID: 6154146 Free PMC article.